SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: CelebrityEquity who wrote (43267)6/14/2017 3:20:46 PM
From: willy613 Recommendations

Recommended By
Fitzhughlaw
patlawche11
watchmymovement

  Read Replies (1) of 63324
 
dont bother hiring him

stock went to 8 and my wife still has me in the garage WITH full representation from FITZ ..:)

With regards to weakness in stock , it prob got a little ahead of itself short term, 6.95 - 7.20 sshould be great support. I do think a high profile CEO would send us north of 10 with that being the death knell for a majority of the shorts and keep the stock above 8 .5 for rest of year if it comes soon. With the slowing down if the other indications(according to Chau) we might not get the BTD for bladder this year , hope I am wrong on that. The Cowen upgrade should also provide support as will the new institutional positions which will begin to filter out in JULY.. Personally I will be surprised if there is not a significant new position by the Baker Bros considering their role in SGEN
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News